Status:
ACTIVE_NOT_RECRUITING
Real-Time fMRI to Enhance Interventions That Change Delay Discounting
Lead Sponsor:
Virginia Polytechnic Institute and State University
Collaborating Sponsors:
Fralin Biomedical Research Institute
Conditions:
Alcohol Use Disorder (AUD)
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The investigators will use real-time fMRI neurofeedback to enhance participants' ability to control their temporal window, and hence their ability to modulate delay discounting and alcohol valuation.
Detailed Description
Based on 8 years of experience recruiting alcohol users into studies of comparable length and complexity, the investigators anticipate that 92% of consented participants will be eligible (i.e., random...
Eligibility Criteria
Inclusion
- demonstrate high-risk or harmful drinking (AUDIT\>15)
- be 21 years of age or older
- have a desire to quit or cut down on their drinking, but do not have proximate plans to enroll in treatment for AUD during the study period
Exclusion
- meeting moderate to severe DSM-5 criteria for substance-use disorders other than alcohol or nicotine
- having a current diagnosis of any psychotic disorder
- having a history of seizure disorders or traumatic brain injury
- having any contraindication for participation in the MRI sessions
- reporting current pregnancy or lactation
Key Trial Info
Start Date :
January 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04828577
Start Date
January 13 2023
End Date
August 31 2025
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States, 24016